Literature DB >> 12399521

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

Wayne J G Hellstrom1, Marc Gittelman, Gary Karlin, Thomas Segerson, Marc Thibonnier, Terry Taylor, Harin Padma-Nathan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12399521

Source DB:  PubMed          Journal:  J Androl        ISSN： 0196-3635


× No keyword cloud information.
  45 in total

1.  Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials.

Authors:  Roland Heinig; Boris Weimann; Hartmut Dietrich; Michael-Friedrich Böttcher
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 2.  [Erectile dysfunction. New drugs with special consideration of the PDE 5 inhibitors].

Authors:  H Porst
Journal:  Urologe A       Date:  2004-07       Impact factor: 0.639

3.  Routine cardiac assessment is not necessary for all patients with erectile dysfunction.

Authors:  Naif Alhathal; Serge Carrier
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

Review 4.  Role of sGC-dependent NO signalling and myocardial infarction risk.

Authors:  Jana Wobst; Thorsten Kessler; Tan An Dang; Jeanette Erdmann; Heribert Schunkert
Journal:  J Mol Med (Berl)       Date:  2015-03-04       Impact factor: 4.599

5.  Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Authors:  V Fonseca; A Seftel; J Denne; P Fredlund
Journal:  Diabetologia       Date:  2004-11-25       Impact factor: 10.122

6.  Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.

Authors:  John P Mulhall; Martin Carlsson; Vera Stecher; Li-Jung Tseng
Journal:  J Sex Med       Date:  2018-05-09       Impact factor: 3.802

Review 7.  A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 8.  Erectile dysfunction and cardiovascular disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions.

Authors:  Ajay Nehra
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 9.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

Review 10.  Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database.

Authors:  F Giuliano; G Jackson; F Montorsi; A Martin-Morales; P Raillard
Journal:  Int J Clin Pract       Date:  2009-11-09       Impact factor: 2.503
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.